Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study.

Wei, Ran; Dean, Dylan C; Thanindratarn, Pichaya; Hornicek, Francis J; Guo, Wei; Duan, Zhenfeng

Wei, Ran; Dean, Dylan C; Thanindratarn, Pichaya; Hornicek, Francis J; Guo, Wei; Duan, Zhenfeng.

Afiliação

Wei R; Musculoskeletal Tumor Center, Beijing Key Laboratory of Musculoskeletal Tumor, Peking University People's Hospital, Beijing, China.
Dean DC; Sarcoma Biology Laboratory, Department of Orthopedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Thanindratarn P; Sarcoma Biology Laboratory, Department of Orthopedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Hornicek FJ; Sarcoma Biology Laboratory, Department of Orthopedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Guo W; Department of Orthopedic Surgery, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Bangkok, Thailand.
Duan Z; Sarcoma Biology Laboratory, Department of Orthopedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.

Front Oncol ; 10: 596330, 2020.

Article em En | MEDLINE | ID: mdl-33282745

Palavras-chave

biomarker; chordoma; cyclin E1; immunohistochemical staining; prognosis; tissue microarray

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google